The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
Open accessAbstract
BACKGROUND: The World Health Organization recommends drug-susceptibility testing of Mycobacterium tuberculosis complex for all patients with tuberculosis to guide treatment decisions and improve outcomes. Whether DNA sequencing can be used to accurately predict profiles of susceptibility to first-line antituberculosis drugs has not been clear. METHODS: We obtained whole-genome sequences and associated phenotypes of resistance or susceptibility to the first-line antituberculosis drugs isoniazid, rifampin, ethambutol, and pyrazinamide for isolates from 16 countries across six continents. For each isolate, mutations associated with drug resistance and drug susceptibility were identified across nine genes, and individual phenotypes were predicted unless mutations of unknown association were also present. To identify how whole-genome sequencing might direct first-line drug therapy, complete susceptibility profiles were predicted. These profiles were predicted to be susceptible to all four drugs (i.e., pansusceptible) if they were predicted to be susceptible to isoniazid and to the other drugs or if they contained mutations of unknown association in genes that affect susceptibility to the other drugs. We simulated the way in which the negative predictive value changed with the prevalence of drug resistance. RESULTS: A total of 10,209 isolates were analyzed. The largest proportion of phenotypes was predicted for rifampin (9660 [95.4%] of 10,130) and the smallest was predicted for ethambutol (8794 [89.8%] of 9794). Resistance to isoniazid, rifampin, ethambutol, and pyrazinamide was correctly predicted with 97.1%, 97.5%, 94.6%, and 91.3% sensitivity, respectively, and susceptibility to these drugs was correctly predicted with 99.0%, 98.8%, 93.6%, and 96.8% specificity. Of the 7516 isolates with complete phenotypic drug-susceptibility profiles, 5865 (78.0%) had complete genotypic predictions, among which 5250 profiles (89.5%) were correctly predicted. Among the 4037 phenotypic profiles that were predicted to be pansusceptible, 3952 (97.9%) were correctly predicted. CONCLUSIONS: Genotypic predictions of the susceptibility of M. tuberculosis to first-line drugs were found to be correlated with phenotypic susceptibility to these drugs. (Funded by the Bill and Melinda Gates Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in other areas of medicine have also found lower NPVs of even highly sensitive and specific tests in situations where the pretest probability of a disease is high23,26,27.”
From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads
Lunter, G., & Goodson, M. (2011) · Genome Research · doi:10.1101/gr.111120.110 · Cited by 1,016
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W. O., Gray, C. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,007
De novo assembly and genotyping of variants using colored de Bruijn graphs
Iqbal, Z., Cáccamo, M., Turner, I., Flicek, P., & McVean, G. (2012) · Nature Genetics · doi:10.1038/ng.1028 · Cited by 652
Walker, T. M., Kohl, T. A., Omar, S. V., Hedge, J., Elías, C. D. O., Bradley, P., Iqbal, Z., Feuerriegel, S., Niehaus, K. E., Wilson, D. J., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00062-6 · Cited by 626
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Casali, N., Nikolayevskyy, V., Balabanova, Y., Harris, S. R., Ignatyeva, O. A., Kontsevaya, I., Corander, J., Bryant, J. M., Parkhill, J., Nejentsev, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2878 · Cited by 465
Votintseva, A. A., Bradley, P., Pankhurst, L. J., Elías, C. D. O., Loose, M., Nilgiriwala, K. S., Chatterjee, A., Smith, E. G., Sanderson, N. D., Walker, T. M., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02483-16 · Cited by 344
Miotto, P., Tessema, B., Tagliani, E., Chindelevitch, L., Starks, A. M., Emerson, C., Hanna, D. L., Kim, P. S., Liwski, R., Zignol, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01354-2017 · Cited by 343
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Pankhurst, L. J., Elías, C. D. O., Votintseva, A. A., Walker, T. M., Cole, K., Davies, J., Fermont, J. M., Gascoyne‐Binzi, D., Kohl, T. A., Kong, C., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00466-x · Cited by 327
Cited by
Sorted by citations
Items 301–400 of 500
Contemporary Concise Review 2018: Respiratory infections and tuberculosis
Hui, D. S. C., & Leung, C. C. (2019) · Respirology · doi:10.1111/resp.13542 · Cited by 7
Wheeler, N. E., Reuter, S., Chewapreecha, C., Lees, J. A., Blane, B., Horner, C., Enoch, D., Brown, N. M., Török, M. E., Aanensen, D. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/758144 · Cited by 8
A data compendium of Mycobacterium tuberculosis antibiotic resistancePreprint
Brankin, A. E., & Malone, K. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.460274 · Cited by 7
Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight?
Park, M., Satta, G., & Haldar, P. (2024) · Thorax · doi:10.1136/thorax-2024-221409 · Cited by 6
Evolution, Phylogenetics, and Phylogeography of Mycobacterium tuberculosis complex
Sola, C., Владиславович, М. И., Sahal, M. R., La, K., Senelle, G., Guyeux, C., Refrégier, G., & Cambau, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28818-0.00025-2 · Cited by 6
Munro, J. E., Coussens, A. K., & Bahlo, M. (2025) · Communications Biology · doi:10.1038/s42003-025-07705-9 · Cited by 6
Ou, X., Pei, S., Li, H., Qin, Z., Anthony, R. M., Wang, J., Song, Z., Xing, R., Zhang, L., Teng, C., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1584237 · Cited by 6
Jia, X., Xiong, Y., Xu, Y., Chen, F., Han, P., Qu, J., He, Q., & Rao, G. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00556-25 · Cited by 6
Application of Next-Generation Sequencing in Public Health Epidemiology and Outbreak Investigation
Tran, A., & Rowlinson, M. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.07.007 · Cited by 6
Lapierre, S. G., Nouvet, É., Boutin, C.-A., Rabodoarivelo, M. S., Mahboob, O., Smith, M. J., & Rakotosamimanana, N. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066651 · Cited by 6
Shea, J., Halse, T. A., Modestil, H., Kearns, C., Fowler, R. C., Costa-Carter, C.-A. D., Siemetzki-Kapoor, U., Leisner, M., Lapierre, P., Kohlerschmidt, D. J., et al. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102380 · Cited by 6
Chang, S. Y., Price, T. K., Beaird, O. E., Gaynor, P. T., Schaenman, J. M. D., Carlson, M., Kubak, B., Yang, S., & Multani, A. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13822 · Cited by 6
Swargam, S., Kumari, I., Kumar, A., Pradhan, D., Alam, A., Singh, H., Jain, A., Devi, K. R., Trivedi, V., Sarma, J., et al. (2022) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2021.805338 · Cited by 6
Puyén, Z. M., Santos-Lázaro, D., Vigo, A. N., Coronel, J., Alarcón, M. J., Cotrina, V. V., & Moore, D. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07677-9 · Cited by 6
How quickly can we predict trimethoprim resistance using alchemical free energy methods?
Fowler, P. W. (2020) · Interface Focus · doi:10.1098/rsfs.2019.0141 · Cited by 6
Ng, K. C. S., Ngabonziza, J. C. S., Lempens, P., de Jong, B. C., van Leth, F., & Meehan, C. J. (2019) · PeerJ · doi:10.7717/peerj.7564 · Cited by 6
Rapid Pyrazinamide Drug Susceptibility Testing using a Closed-Tube PCR Assay of the Entire pncA gene
Whitfield, M. G., Marras, S. A. E., Warren, R. M., Rie, A. V., Rice, J., Wangh, L. J., & Kreiswirth, B. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-61286-7 · Cited by 6
Ding, F., Liu, W., Wu, C., Zhang, W., Chen, S., Lai, W., Qu, J., Lin, Q., Lu, S., & Qu, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1488547 · Cited by 5
Li, H., Zhang, G., Ma, Z., Guo, H., Shang, Y., Yao, C., Li, S., Pang, Y., & Pan, J. (2025) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-025-00807-6 · Cited by 5
How Artificial Intelligence Assists in Overcoming Drug Resistance?
Ndikuryayo, F., Gong, X., Hao, G., & Yang, W. (2025) · Medicinal Research Reviews · doi:10.1002/med.70002 · Cited by 5
Farzand, R., Haigh, R., Monk, P., Haldar, P., Patel, H., Pareek, M., Verma, R., Barer, M. R., Woltmann, G., Ahyow, L., et al. (2022) · mBio · doi:10.1128/mbio.02656-22 · Cited by 5
Kuruwa, S., Zade, A., Shah, S., Rameez, M. J., Lad, S. B., Chande, C., Joshi, A., Hirani, N., Nikam, C., Bhattacharya, S., et al. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae037 · Cited by 5
Wei, L., Chen, J., Deng, Z., Zhang, Z., Zhang, Z., & Duan, Q. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1442987 · Cited by 5
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results
Yee, R., & Simner, P. J. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.07.008 · Cited by 5
Otto-Knapp, R., Knappik, M., Häcker, B., Starzacher, K., Bauer, T. T., Lange, C. G., Maurer, F. P., Schaberg, T., & Günther, G. (2020) · Pneumologie · doi:10.1055/a-1266-5207 · Cited by 5
Qadir, M., Tahseen, S., McHugh, T. D., Hussain, A., Masood, F., Ahmed, N., & Faryal, R. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.06.020 · Cited by 5
The crucial need for tuberculosis translational research in the time of COVID-19
Loh, F. K., Thong, P. M., & Ong, C. W. M. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00099-6 · Cited by 5
Zenteno‐Cuevas, R., Fernandez, E., Viveros, D., Madrazo-Moya, C. F., Cancino‐Muñoz, I., Comas, I., González-Covarrubias, V., Barbosa-Amezcua, M., & Cuevas-Córdoba, B. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0054 · Cited by 5
Combination of Xpert MTB/RIF and MTBDRplus for Diagnosing Tuberculosis in a Chinese District
Lv, C., Wu, J., Pierre-Audigier, C., Lu, L., Emane, A. K. A., Takiff, H. E., Xu, Y., Wang, J., Gicquel, B., & Liu, S. (2020) · Medical Science Monitor · doi:10.12659/msm.923508 · Cited by 5
George, S. A., Xu, Y., Rodger, G., Morgan, M. R., Sanderson, N. D., Hoosdally, S., Thulborn, S., Robinson, E., Rathod, P., Walker, A. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.05.026864 · Cited by 5
Westhead, J., Baker, C. S., Brouard, M. J., Colpus, M., Constantinides, B., Hall, A., Knaggs, J., Alves, M. L., Spies, R., Thai, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.08.622466 · Cited by 5
Saluzzo, F., Cabibbe, A. M., Anthony, R. M., Aubry, A., Drobniewski, F. A., Holicka, Y., Lillebæk, T., Macedo, R., Mansjö, M., Szél, V., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101516 · Cited by 4
Zhu, F., Peng, M., Chen, A., & Zhu, Q.-Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1712752 · Cited by 5
Lee, S. H., Ferran, E., Witney, A. A., Ryu, S., Kang, H., Storey, N., McHugh, T. D., & Satta, G. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad056 · Cited by 4
Qadir, M., Khan, M. T., Khan, S. A., Akram, M., Canseco, J. O., Faryal, R., Wei, D. Q., & Tahseen, S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001884 · Cited by 4
Pozzoli, U., Forni, D., Arrigoni, F., Cagliani, R., GIOIA, L. D., & Sironi, M. (2025) · Genome biology · doi:10.1186/s13059-025-03854-6 · Cited by 4
Horan, K., Viberg, L. T., Ballard, S. A., Globan, M., Wirth, W., Bond, K. A., Webb, J. R., Dorji, T., Williamson, D. A., Sait, M. L., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100939 · Cited by 4
Molecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review
Nguyen, M., MacLean, E. L.-H., Zhang, X., Georghiou, S. B., Xia, H., Beardsley, J., Sheel, M., Nguyen, T.-A. T., Marais, B. J., & Fox, G. J. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101362 · Cited by 4
Drysdale, S. B., Kelly, D. F., Morgan, M. R., Peto, T., Crook, D. W., Matthews, P. C., & Walker, T. M. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16280.1 · Cited by 4
Sharma, T., Kumar, R., Kalra, J. S., Singh, S., Bhalla, G. S., & Bhardwaj, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1041847 · Cited by 4
Introduction to Tuberculosis: Integrated Studies for a Complex Disease
Rezaei, N., Hosseini, N., & Saghazadeh, A. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_1 · Cited by 4
Zhang, G., Sun, X., Fleming, J., Ran, F., Luo, J., Chen, H., Ju, H., Wang, Z., Zhao, H., Wang, C., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.01.016 · Cited by 4
Universal Lineage-Independent Markers of Multidrug Resistance in Mycobacterium tuberculosis
Hlanze, H., Mutshembele, A., & Reva, O. N. (2024) · Microorganisms · doi:10.3390/microorganisms12071340 · Cited by 4
Drugs against Mycobacterium tuberculosis
Singh, R., Kumar, P., & Tahlan, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00006-0 · Cited by 4
Chapter 11: Tuberculosis contact investigation and outbreak management
Rea, E., Huard, J., & Lee, R. S. (2022) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2022.2037909 · Cited by 4
Diversity and novel mutations in membrane transporters ofMycobacterium tuberculosis
Khan, M. T., Khan, T. A., Ahmad, I., Muhammad, S., & Wei, D. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac018 · Cited by 4
The case for including microbial sequences in the electronic health record
Sintchenko, V., & Coiera, E. W. (2023) · Nature Medicine · doi:10.1038/s41591-022-02157-8 · Cited by 4
Yan, M., Zhao, Z., Wu, T., Liu, T., Xu, G., Xu, H. Y., & Ying, B. (2023) · Small Methods · doi:10.1002/smtd.202201322 · Cited by 4
Syed, R. R., Catanzaro, D. G., Colman, R. E., Cooney, C. G., Linger, Y., Kukhtin, A. V., Holmberg, R. C., Norville, R., Crudu, V., Ciobanu, N., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01478-22 · Cited by 4
Prommi, A., Wongjarit, K., Petsong, S., Somsukpiroh, U., Faksri, K., Kawkitinarong, K., Payungporn, S., & Rotcheewaphan, S. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03462-23 · Cited by 4
Walker, T. M., Miotto, P., Köser, C. U., Fowler, P. W., Knaggs, J., Iqbal, Z., Hunt, M., Chindelevitch, L., Farhat, M. R., Cirillo, D. M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3923444 · Cited by 4
A chemical-genetic map of the pathways controlling drug potency in Mycobacterium tuberculosisPreprint
Li, S., Poulton, N. C., Chang, J. S., Azadian, Z. A., DeJesus, M. A., Ruecker, N., Zimmerman, M. D., Eckartt, K. A., Bosch, B., Engelhart, C. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.27.469863 · Cited by 4
Predicting MmpR-based bedaquiline resistance using sequence- and structure-based featuresPreprint
Rivière, E., Safarpour, M., Meysman, P., Cuypers, B., Meehan, C. J., Laukens, K., & Rie, A. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.19.521152 · Cited by 3
Hsueh, S.-C., Chen, C., Lin, C.-R., Lin, H.-H., Lee, T.-F., Tseng, K.-H., Chu, H.-W., Lee, C.-L., Hsu, W.-Y., Huang, Y., et al. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107605 · Cited by 3
Sakaguchi, T., Irifune, Y., Kamada, R., & Sakaguchi, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199326 · Cited by 7
Kim, Y., Lee, D., Bae, J., Jung, J., Jeon, H., Chung, M., Park, J., Ahn, K., Mun, J.-W., Jang, Y., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05319-x · Cited by 3
Westhead, J., Baker, C. S., Brouard, M. J., Colpus, M., Constantinides, B., Hall, A., Knaggs, J., Alves, M. L., Spies, R., Thai, H., et al. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001592 · Cited by 3
Tamilzhalagan, S., Justin, E. S., Selvaraj, A., Venkateswaran, K., Sivakumar, A. K., Chittibabu, S., McLaughlin, H. P., Moonan, P. K., Smith, J. P., Sakthi, S., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1515627 · Cited by 3
Rajendran, A., Refaya, A. K., Subramanyam, B., Karunaianantham, R., Ravikumar, D., Haribabu, H., Gopalaswamy, R., Golla, R., Senthildevi, V., Sivaramakrishnan, G. N., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100462 · Cited by 3
Liu, P., Zhang, J., Gong, Y., Liu, W., Xiao, G., Liang, J. B., Wang, X., Bi, J., & Zhang, G. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00165-25 · Cited by 3
Identification and Characterization of Mycobacterial Species Using Whole-Genome Sequences
Riojas, M. A., Frank, A. M., Greenfield, S. R., King, S. P., Meehan, C. J., Strong, M., Wattam, A. R., & Hazbón, M. H. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1460-0_19 · Cited by 3
Realegeno, S. E., Adeyiga, O. B., Winston, D. J., Beaird, O. E., Garner, O. B., & Yang, S. (2021) · IDCases · doi:10.1016/j.idcr.2021.e01308 · Cited by 3
Lopez, J. M., Zimic, M., Vallejos-Sánchez, K., Sevilla, D., Quispe-Carbajal, M., Roncal, E., Rodríguez, J., Rodríguez, J., Antiparra, R., Arteaga, H., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01522-22 · Cited by 3
Li, R., Li, Y., Chen, X., Jia, L., Yu, H., Huang, Y., Wu, Q., Xiao, M., Ge, S., Zhang, Y., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04836-22 · Cited by 3
Dippenaar, A., Ismail, N. A., Heupink, T. H., Grobbelaar, M., Loubser, J., Rie, A. V., & Warren, R. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-60545-1 · Cited by 3
Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis
Bahk, K., Sung, J., Seki, M., Kim, K., Kim, J., Choi, H., Whang, J., & Mitarai, S. (2024) · DNA Research · doi:10.1093/dnares/dsae023 · Cited by 3
Song, Y., Abuduaini, B., Yang, X., Zhang, J., Wang, G., & Lu, X. (2025) · Inflammation Research · doi:10.1007/s00011-025-02020-9 · Cited by 3
Ashenden, S. K., Deswal, S., Bulusu, K. C., Bartosik, A., & Shameer, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820045-2.00004-0 · Cited by 4
Meumann, E. M., Krause, V., Baird, R., & Currie, B. J. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080181 · Cited by 3
Kundasamy, P., Kemp, B., Kearns, D. J., McCallum, A., Nazir, S. A., & Lyon, P. C. (2022) · BJR|case reports · doi:10.1259/bjrcr.20220101 · Cited by 3
Furió, V., Moreno-Molina, M., Chiner‐Oms, Á., Villamayor, L. M., Torres‐Puente, M., & Comas, I. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.17.154062 · Cited by 3
Earle, S. G., & Wilson, D. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.460272 · Cited by 3
Drug Resistance Mechanisms in TuberculosisPreprint
Fattorini, L., Iacobino, A., & Giannoni, F. (2020) · doi:10.32545/encyclopedia202004.0004.v5 · Cited by 2
Carter, J. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3378915/v1 · Cited by 3
Horan, K., Viberg, L. T., Ballard, S. A., Globan, M., Wirth, W., Bond, K. A., Webb, J. R., Dorji, T., Williamson, D. A., Sait, M. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.04.565651 · Cited by 3
Analysis of microbial infections with omic techniques
Tang, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00013-7 · Cited by 1
Sheen, P., Monsalve, A., Tineo, J. C., Huerta-Guillén, R., Antiparra, R., Arteaga, H., Duran, P., Bueno, C., Kirwan, D. E., Gilman, R. H., et al. (2019) · Journal of Bacteriology · doi:10.1128/jb.00331-19 · Cited by 2
Conventional and Modern Approaches for Clinical and Laboratory Diagnosis of Tuberculosis
Sharma, M. K., Wonitowy, Q., & Soualhine, H. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_10 · Cited by 2
Pérez-Martínez, D. E., Mejía‐Ponce, P. M., Licona‐Cassani, C., de Igartua, E., Bermúdez, G., Viveros, D., & Zenteno‐Cuevas, R. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_18 · Cited by 2
Song, Z., He, W., Cao, X., Ma, A., He, P., Zhao, B. T., Wang, S., Liu, C., & Zhao, Y. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s437026 · Cited by 2
Rukmana, A., Nurfadilah, M., Gozali, C., & Kiranasari, A. (2024) · Tropical Medicine & International Health · doi:10.1111/tmi.14051 · Cited by 2
Realising the Potential of Genomics for M. tuberculosis: A Silver Lining to the Pandemic?
Walker, T. M., & Crook, D. W. (2022) · PubMed Central · doi:10.46234/ccdcw2022.063 · Cited by 2
Crystal ball: the yesterday and tomorrow of tuberculosis
Sinha, P., & Hochberg, N. S. (2018) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12726 · Cited by 2
Smith, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819613-7.00007-4 · Cited by 2
Miller, B. S., Gliddon, H. D., & McKendry, R. A. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.296715 · Cited by 2
Individualising therapy for drug-sensitive tuberculosis
Esmail, H., Lipman, M. C. I., Nunn, A., & Walker, T. M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30247-4 · Cited by 2
Escuyer, V. E. (2019) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.119.001784 · Cited by 2
Differential Host Gene Signatures in Response to Mycobacterium tuberculosis InfectionPreprint
Tazi, L., Wang, P., & Fornage, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.955203 · Cited by 2
Lachapelle, A. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.458035 · Cited by 2
Estimation of country-specific tuberculosis antibiograms using genomic dataPreprint
Dixit, A., Freschi, L., Vargas, R., Gröschel, M. I., Tahseen, S., Alam, S. M., Kamal, S. M. M., Skrahina, A. M., Basilio, R., Lim, D. R., et al. (2021) · medRxiv · doi:10.1101/2021.09.23.21263991 · Cited by 2
Microbiological Diagnosis of Tuberculosis Disease
Alagna, R., Cabibbe, A. M., Tortoli, E., & Cirillo, D. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-66703-0_10 · Cited by 1
Ametepe, E. S., Andriamanoha, N., Andrianomanana, F. R., Point, F., Mangahasimbola, R. T., Dyachenko, A., Hall, M. B., Gamana, T. M., Knoblauch, A. M., Razafindrasoa, Y. Y., et al. (2024) · Trials · doi:10.1186/s13063-024-08537-4 · Cited by 1
Drug selection based on pan-genomics genetic features of Mycobacterium tuberculosis
Sun, X., Xu, P., Liu, Y., Shi, Y., Wang, N., & Li, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1663069 · Cited by 1
Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars
Zhang, X., Wan, S., Bhati, A. P., Fowler, P. W., & Coveney, P. V. (2025) · mSphere · doi:10.1128/msphere.00571-25 · Cited by 3
Emergence of novel sublineages of Mycobacterium tuberculosis in Pakistan
Khan, M. T., Zhu, C., Khatib, A. O. A., Alshaya, D. S., Al-Qahtani, A. A., Ahmad, I. S., & Clark, T. G. (2025) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2025.151684 · Cited by 1
Dorji, T., Tshering, K., Adhikari, L., Jamtsho, T., Bhujel, P., Lhaden, P., Wangchuk, S., Wirth, W., Horan, K., Denholm, J. V., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf802 · Cited by 1
Kalinich, C. C., Gonzalez, F. L., Osmaston, A., Breban, M. I., Distefano, I., León, C., Coronel, J., Tan, G., Crudu, V., Ciobanu, N., et al. (2026) · Journal of Clinical Microbiology · doi:10.1128/jcm.01823-25 · Cited by 1
Wei, S., Yong, Z., Lin, J., Lin, S., Dai, Z., Lin, Y., & Deng, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-40398-6 · Cited by 1
Park, M., Solanki, P., McHugh, T. D., Kon, O. M., & Satta, G. (2026) · International Journal of Microbiology · doi:10.1155/ijm/8659735 · Cited by 1
Zhu, Y., Wang, W., Chen, T., Liu, R., Yao, J., Cai, Y., Guo, V. Y., Gu, J., Hao, Y., Gilmour, S., et al. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103236 · Cited by 1
Metadata
- Authors
- The CRyPTIC Consortium and the 100, 0. G. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-10-11
- Volume
- 379
- Issue
- 15
- Pages
- 1403-1415
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6121966
- OpenAlex
- W2902271181
- Cited by
- 500
- References
- 22
- Citations by year
- 2026: 25 · 2025: 41 · 2024: 58 · 2023: 61 · 2022: 78 · 2021: 65 · 2020: 89 · 2019: 72 · 2018: 9
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- HAL (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Florence Research (University of Florence) (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Seventh Framework Programme (278864)
- European Research Council (638553-TB-ACCELERATE)
- Wellcome Trust and the Royal Society Sir Henry Dale Fellowships (101237/Z/13/Z, 102541/A/13/Z)
- National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04)
- Ministerio de Economía y Competitividad (SAF2016-77346-R)
- National Science and Technology Key Program of China (2014ZX10003002)
- National Basic Research program of China (2014CB744403)
- Health Services and Delivery Research Programme
- Bill and Melinda Gates Foundation (OPP1133541)
- Wellcome Trust (200205/Z/15/Z)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- Mycobacterium tuberculosis complex, first-line antituberculosis drugs, isoniazid resistance, rifampicin resistance, ethambutol resistance, pyrazinamide resistance, drug resistance mutations, whole genome sequencing, genotype-phenotype correlation, negative predictive value
- MeSH terms
- Whole Genome Sequencing, Antitubercular Agents, Ethambutol, Genotype, Humans, Isoniazid, Microbial Sensitivity Tests, Mutation, Mycobacterium tuberculosis, Phenotype, Pyrazinamide, Rifampin, Tuberculosis, Genome, Bacterial, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review